Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Steele, Ronald A."'
Autor:
Mulatero, Paolo, Wuerzner, Gregoire, Groessl, Michael, Sconfienza, Elisa, Damianaki, Aikaterini, Forestiero, Vittorio, Vogt, Bruno, Brunner, Hans, Gerlock, Teresa, Steele, Ronald, Schumacher, Christoph
Publikováno v:
In eClinicalMedicine May 2024 71
Autor:
Pignatti, Emanuele, Kollar, Jakub, Hafele, Evelyn, Schuster, Daniela, Steele, Ronald E., Vogt, Bruno, Schumacher, Christoph, Groessl, Michael
Publikováno v:
In Journal of Steroid Biochemistry and Molecular Biology December 2023 235
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kuo, Ramsay L, Paterson, Ryan F, Siqueira, Tibério M, Jr, Watkins, Stephanie L, Simmons, Garrick R, Steele, Ronald E, Lingeman, James E
Publikováno v:
In Urology 2003 62(1):59-63
Autor:
KUO, RAMSAY L., KIM, SAMUEL C., LINGEMAN, JAMES E., PATERSON, RYAN F., WATKINS, STEPHANIE L., SIMMONS, GARRICK R., STEELE, RONALD E.
Publikováno v:
In The Journal of Urology 2003 170(1):149-152
Publikováno v:
Journal of Hypertension
Context: We describe the clinical investigation of the first generation aldosterone synthase inhibitor, LCI699, in patients with essential, uncontrolled, resistant, or secondary hypertension. LCI699 competitively reduced blood pressure at lower doses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc65c6a88cb1c8b3c64e91eae79bd434
https://doi.org/10.1097/hjh.0b013e328363570c
https://doi.org/10.1097/hjh.0b013e328363570c
Autor:
Kenneth S. Leonards, Steele Ronald Edward, Jong M. Wasvary, E.C. Yurachek, Zouhair F. Stephan, Chii Whei Hu, Robin Sharif, Thomas H. Hintze
Publikováno v:
Atherosclerosis. 126:53-63
A potent lipid-lowering thyromimetic (CGS 26214) devoid of cardiac and thermogenic activity was identified based on its ability to preferentially access and bind the nuclear fraction of hepatocytes over that of myocytes in culture. The difference in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad869be437aa034f8ff34a204dda59eb
https://doi.org/10.1016/0021-9150(96)05893-5
https://doi.org/10.1016/0021-9150(96)05893-5
Publikováno v:
ChemInform. 22
A new class of potent, selective, nonsteroidal inhibitors of aromatase have been discovered. The most potent member of this series is fadrozole hydrochloride, CGS 16949 A, 4-(5,6,7,8-tetrahydroimidazo[1,5-alpha]pyridin-5-yl)benzonitrile monohydrochlo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d80d75399df8a283aeccc315a8bd1ebf
https://doi.org/10.1002/chin.199139167
https://doi.org/10.1002/chin.199139167
Autor:
Colin Howes, Jong M. Wasvary, Zouhair F. Stephan, Steele Ronald Edward, E.C. Yurachek, Robin Sharif
Publikováno v:
Biochemical Pharmacology. 43:1969-1974
This study was designed to determine whether the conjugation product of L-T3 with cholic acid would result in a liver-targeted compound (CGH 509A) with hypocholesterolemic (HC) activity significantly dissociable from cardiovascular (CV) and thyroxine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::872b49e1c5c310ef8e43a1991ec4865f
https://doi.org/10.1016/0006-2952(92)90640-5
https://doi.org/10.1016/0006-2952(92)90640-5
Publikováno v:
Journal of Medicinal Chemistry. 34:725-736
A new class of potent, selective, nonsteroidal inhibitors of aromatase have been discovered. The most potent member of this series is fadrozole hydrochloride, CGS 16949 A, 4-(5,6,7,8-tetrahydroimidazo[1,5-alpha]pyridin-5-yl)benzonitrile monohydrochlo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bca54eec9f31f684165f1bde0ef426b4
https://doi.org/10.1021/jm00106a038
https://doi.org/10.1021/jm00106a038